Antimicrobial resistance grants
This article was originally published in The Tan Sheet
Executive Summary
CDC announces availability of roughly $600,000 in grant funding for fiscal 2002 for applied research aimed at "prevention and control of the emergence and spread of antimicrobial resistance" in U.S. Program will focus on validation of National Committee for Clinical Laboratory Standards breakpoints for human pathogens of public health importance, according to June 4 Federal Register notice. Research, in form of three separate $200,000 grants, is expected to begin Aug. 30 and continue for up to three years, CDC says. Completed application forms, available on 1CDC Web site, are due July 16...You may also be interested in...
Sales Already Growing As Vascepa Secures Cardio Approval
Company forecast 2020 sales as high as $700m as regulator grants broad label.
Belgium Outlaws OTC Cough And Cold Combination Drugs
Safety concerns prompt Belgium's drug regulator to order all OTC fixed combination products for coughs and colds removed from shelves.
Allegations Of EU Notified Body Fees Having Escalated And Of Being Unpredictable
US medtech companies are worried EU notified bodies have too much freedom over setting their fees, accusing them of lacking transparency and being inconsistent with what they charge. They also allege that notified body practices mean some products will miss the four-year grace period.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: